Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
Revolution Medicines, Inc.
Leiden University Medical Center
University of California, San Diego
Verrica Pharmaceuticals Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, San Francisco
Centre Hospitalier Universitaire de Nice
Eastern Cooperative Oncology Group
University of Kentucky
University of Kentucky
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Catalysis SL
University of Florida
UCB Pharma
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Assistance Publique - Hôpitaux de Paris
Eli Lilly and Company
University of Kentucky
Eli Lilly and Company
Mereo BioPharma
Acrotech Biopharma Inc.
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
University College, London
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Spanish Oncology Genito-Urinary Group
Novartis
Dartmouth-Hitchcock Medical Center
Pfizer
Neovii Biotech
Sunesis Pharmaceuticals
University of Pittsburgh
Sunesis Pharmaceuticals
University of Chicago
Washington University School of Medicine
Yale University
Sunesis Pharmaceuticals
Dendreon
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Novartis
Novartis
Novartis
Merck KGaA, Darmstadt, Germany